Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Hypertension prevention with 2'-FL yogurt

ABSTRACT: L-NAME-induced hypertensive mice were administered 2'-fucosyllactose-enriched yogurt to evaluate its potential antihypertensive and gut microbiota-modulating effects.

PROVIDER: PRJEB89989 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR15092800_1.fastq.gz	Fastqsanger.gz
	ERR15092800_2.fastq.gz	Fastqsanger.gz
	ERR15092801_1.fastq.gz	Fastqsanger.gz
	ERR15092801_2.fastq.gz	Fastqsanger.gz
	ERR15092802_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 120

Similar Datasets

Ant yogurt LC-MS caseinolytic potential

Project description:Our hypothesis was that the ant holobiont may contribute enzymes, in particular proteases, that modify the yogurt texture. To test this hypothesis, we conducted an untargeted proteomics analysis based on a self-curated database that contained proteases from Formica ants, ant-yogurt bacteria, conventional yogurt bacteria, and milk proteins.

2025-08-01 | PXD057843 | Pride

Lactiplantibacillus plantarum strain:yogurt | isolate:yogurt

Project description:Lactiplantibacillus plantarum strain:yogurt | isolate:yogurt Genome sequencing

| PRJNA1259204 | ENA

Pediococcus acidilactici strain:yogurt | isolate:yogurt

Project description:Pediococcus acidilactici strain:yogurt | isolate:yogurt Genome sequencing

| PRJNA1114319 | ENA

Effect of Egg Protein Ovotransferrin-derived Peptide, IRW on Gene Expression of Vascular Tissues in Spontaneously Hypertensive Rats

Project description:In this study we tested the effect of orraly administered egg white ovotransferrin derived pepide, IRW on gene expression in spontaneously hypertensive rats. IRW is previously identified with antihypertensive effect and in this study we evaluated how IRW treatment can modulate various gene expression.

2017-02-09 | GSE65017 | GEO

Yogurt metagenome

Project description:Yogurt metagenome Metagenome

| PRJNA733702 | ENA

Comparison of gene expressions between LB81 yogurt-intake mice and control mice in the intestine, liver and spleen at 28 months of age

Project description:We performed the long-term administration experiment using a yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 (LB81 yogurt) for 20 months in order to understand the effects of the long-term intake of probiotics on mice. Microarrays were used to compare the gene expressions of the intestine, liver and spleen tissues between control mice and LB81 yogurt-intake mice at 28 months of age. Abbreviations used: A, LB81 yogurt-intake mice; C, control mice

2018-06-02 | GSE104375 | GEO

Fermentation of soy juice by Lactiplantibacillus plantarum confers a yogurt-like texture, flavours and health-promoting metabolites

Project description:The aim of the study was to decipher metabolisms responsible (i) for the peculiar adaptation of L. plantarum during soy juice fermentation and (ii) for the release of aroma compounds, amino and short-chain fatty acid, and metabolites with health-promoting properties in soy yogurt. The strategy was the sequencing and annotation of a strain (L. plantarum CIRM-BIA777, PRJEB77707) able to degrade galacto- oligosaccharides, the sampling of soy yogurt, RNA-seq to identify differentially expressed genes of L. plantarum and corresponding metabolisms throughout the kinetics of fermentation. Acids and volatile compounds were also quantified.

2024-08-18 | E-MTAB-14345 | biostudies-arrayexpress

Dried Yellow Persian Yogurt

Project description:Dried Yellow Persian Yogurt Raw sequence reads

| PRJNA530738 | ENA

Probiotic yogurt on chemotherapy-induced diarrhea

Project description:Intervention 1: Intervention group: Symptomatic treatment (Loperamide 4mg followed by 2 mg every 4 hours) with Probiotic yogurt (150 Grams) before breakfast and dinner twice a day for one week. Intervention 2: Control group: Symptomatic treatment Symptomatic treatment (Loperamide 4mg followed by 2 mg every 4 hours) with Regular yogurt (150 Grams) before breakfast and dinner twice a day for one week. Intervention 3: Control group: Symptomatic treatment Symptomatic treatment (Loperamide 4mg followed by 2 mg every 4 hours) with No intervention. Primary outcome(s): Diarrhea frequency. Timepoint: Daily for one week after the start of the Intervention. Method of measurement: Patient’s report.;Diarrhea intensity. Timepoint: Daily for one week after the start of the Intervention. Method of measurement: Patient’s report.;Stool consistency. Timepoint: Daily for one week after the start of the Intervention. Method of measurement: Observation. Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The study subjects were randomly allocated to yogurt + probiotic, yogurt, and control groups using Random Allocation Software (RAS) through random block sizes of 6 with an allocation ratio of 1:1. Random sequencing allocation was produced by the person who did not participate in the Sampling. The software produces sequences with 2 samples in each group. Containers were numbered from 1 to 90 according to the sequence generated.

| 2475794 | ecrin-mdr-crc

Lacticaseibacillus rhamnosus strain:S22825 | isolate:yogurt

Project description:Lacticaseibacillus rhamnosus strain:S22825 | isolate:yogurt Genome sequencing

| PRJNA1055183 | ENA